ISO Group Logo
Defense and Aerospace
Supply Chain Partner
A Dynatech International Company


NSN 6505-01-080-2377, 6505010802377
Cancelled -> Replaced by 6505012403834

Federal Supply Classification
FSC 6505 - Drugs and Biologicals
National Item Identification Number
NIIN 010802377
Codification Country
United States
Item Name Code
INC 34464
Criticality
(X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code
(P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.
Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know
  CALL ABOUT NSN 6505-01-080-2377
Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

  REQUEST QUOTE for 6505-01-080-2377


Have a list that needs to be quoted? Upload it here.

DLMS® Summary

National Stock Number 6505-01-080-2377

National Stock Number (NSN) 6505-01-080-2377, or NIIN 010802377, (pancrelipase tablets,usp) was assigned July 21, 1979 in the Federal Logistics Information System (FLIS). NIIN 010802377 was cancelled on March 2, 2016, with a cancelled status of "Item is Cancelled WITHOUT Replacement." There is no known replacement specified for this stock number. This NSN replaces 1 stock number, 6505012403834.

There are 2 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Oct 30, 2020, this NSN's acquisition method was noted as: Not established. Not established.

This NSN is assigned to Item Name Code (INC) 34464. []. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505010802377 does not contain precious metals.

This information was last updated on .


Technical Characteristics

ADMINISTRATION
(CSGS) ORAL
ACTIVE MEDICAMENT MEDICINAL STRENGTH
(AKJA) 325.000 MILLIGRAMS PANCREATIN ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE
(CQCT) BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY
(CRLK) 500.000 TABLETS
PART NAME ASSIGNED BY CONTROLLING AGENCY
(CXCY) PANCRELIPASE TABLETS USP 325 MG 500S BT
SUPPLEMENTARY FEATURES
(SUPP) PORCINE OR BOVINE ORIGIN
SPECIAL FEATURES
(FEAT) ENZYME POTENCY PER TABLET IS AMYLASE 30,000 USP UNITS,LIPASE 8000 USP UNITS,AND PROTEASE 30,000 USP UNITS

Manufacturer Part Numbers


Related Inventory



 
Top